Duwat, Lilibeth L.
HRN: 27-37-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2025
CO-AMOXICLAV 625MG (TAB)
06/28/2025
07/07/2025
PO
625 Mg
TID
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes